Amneal Pharmaceuticals Officer Sells $3,654,000 in Stock
Jason B. Daly sold 210,000 shares of Amneal Pharmaceuticals on August 12, 2026, according to an SEC filing.
2 reports on this incident · first at Aug 17, 2026, 10:15 a.m. ET
Earlier reports
Aug 17, 2026, 10:15 a.m. ETFirst report
Amneal Pharmaceuticals EVP Jason B. Daly Sells 210,000 Shares
According to an SEC Form 4 insider transaction filing, Jason B. Daly, EVP and Chief Legal Officer at Amneal Pharmaceuticals, Inc. (AMRX), sold 210,000 shares of common stock on August 12, 2026.
The shares were sold at $17.4 per share for a total value of $3,654,000. Official SEC filing records state that the transaction was not conducted under a trading plan. Following the sale, Daly holds 35,171 shares in the Bridgewater, NJ-based company. Daly's address is listed in Bridgewater, NJ.
Was this report accurate and useful?
Sources
Revision history
- Version 318 Aug 2026, 12:23current
Updated share price and total transaction values to match exact dollar formatting from official SEC filing records.
- Version 217 Aug 2026, 14:15current
Updated report with SEC Form 4 filing source citation and insider location details.
- Version 217 Aug 2026, 14:20
Formatted report into required JSON structure including headline, dek, body markdown, and sources cited.
- Version 115 Aug 2026, 16:57
First published.
- Version 115 Aug 2026, 16:29
First published.
How we work
This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.
Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.
Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.
None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.